Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicole M King, Albin S Quiko, James G Slotto, Nicholas C Connolly, Robert J Hackworth & Justin W Heil. (2016) Retrospective analysis of quality improvement when using liposome bupivacaine for postoperative pain control. Journal of Pain Research 9, pages 233-240.
Read now
Read now
Articles from other publishers (19)
Elise Becker, Amy Hernandez, Howard Greene, Kyle Gadbois, David Gallus & Gordon Wisbach. (2022) Does Liposomal Bupivacaine Decrease Postoperative Opioid Use in Conjunction with an Enhanced Recovery After Bariatric Surgery Pathway? A Prospective, Double-blind, Randomized Controlled Trial. Obesity Surgery 33:2, pages 555-561.
Crossref
Crossref
Anh Thu Tran, Elsie Rizk, Eric M. Haas, George Naufal, Lixian Zhong & Joshua T. Swan. (2022) Real-World Data on Liposomal Bupivacaine and Inpatient Hospital Costs After Colorectal Surgery. Journal of Surgical Research 272, pages 175-183.
Crossref
Crossref
Lea Villadiego & B. Wycke Baker. (2021) Improving Pain Management After Cesarean Birth Using Transversus Abdominis Plane Block With Liposomal Bupivacaine as Part of a Multimodal Regimen. Nursing for Women's Health 25:5, pages 357-365.
Crossref
Crossref
Francis J. Zamora, Rani P. Madduri, Ashmi A. Philips, Nancy Miller & Mini Varghese. (2019) Evaluation of the Efficacy of Liposomal Bupivacaine in Total Joint Arthroplasty. Journal of Pharmacy Practice 34:3, pages 403-406.
Crossref
Crossref
J. Lacie Bradford, Beatrice Turner & Megan A. Van Berkel. (2019) Effect of Liposomal Bupivacaine on Postoperative Opioid Requirements for Total Hip Arthroplasty, Total Knee Arthroplasty, Laminectomy, Hysterectomy, and Abdominoplasty Procedures. Hospital Pharmacy 56:1, pages 59-66.
Crossref
Crossref
Brian M. Ilfeld, James C. Eisenach & Rodney A. Gabriel. (2020) Clinical Effectiveness of Liposomal Bupivacaine Administered by Infiltration or Peripheral Nerve Block to Treat Postoperative Pain. Anesthesiology 134:2, pages 283-344.
Crossref
Crossref
Isra Omar, Husna Mirza & Sebastien Taurin. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
445
466
.
Jeffrey Huang, Cathy Cao, Gregg Nelson & R. Douglas Wilson. (2019) A Review of Enhanced Recovery After Surgery Principles Used for Scheduled Caesarean Delivery. Journal of Obstetrics and Gynaecology Canada 41:12, pages 1775-1788.
Crossref
Crossref
Ronak A. Patel, Eric M. Jablonka, Kristine C. Rustad, Brian C. Pridgen, Sarah S. Sorice-Virk, Mimi R. Borrelli, Rohit K. Khosla, H. Peter Lorenz, Arash Momeni & Derrick C. Wan. (2019) Retrospective cohort-based comparison of intraoperative liposomal bupivacaine versus bupivacaine for donor site iliac crest analgesia during alveolar bone grafting. Journal of Plastic, Reconstructive & Aesthetic Surgery 72:12, pages 2056-2063.
Crossref
Crossref
Atuhani Burnett, Brian Faley, Themba Nyirenda & Zubin M. Bamboat. (2018) Liposomal bupivacaine reduces narcotic use and time to flatus in a retrospective cohort of patients who underwent laparotomy. International Journal of Surgery 59, pages 55-60.
Crossref
Crossref
Roy Davidovitch, Abraham Goch, Adam Driesman, Sanjit Konda, Christian Pean & Kenneth Egol. (2017) The Use of Liposomal Bupivacaine Administered With Standard Bupivacaine in Ankle Fractures Requiring Open Reduction Internal Fixation: A Single-Blinded Randomized Controlled Trial. Journal of Orthopaedic Trauma 31:8, pages 434-439.
Crossref
Crossref
Thomas W Hamilton, Vassilis Athanassoglou, Stephen Mellon, Louise H H Strickland, Marialena Trivella, David Murray & Hemant G Pandit. (2017) Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain. Cochrane Database of Systematic Reviews 2020:2.
Crossref
Crossref
Kristy Bultema, Sara Fowler, Melissa Drum, Al Reader, John Nusstein & Mike Beck. (2016) Pain Reduction in Untreated Symptomatic Irreversible Pulpitis Using Liposomal Bupivacaine (Exparel): A Prospective, Randomized, Double-blind Trial. Journal of Endodontics 42:12, pages 1707-1712.
Crossref
Crossref
Suzette G. Miranda, Yusha Liu, Shane D. Morrison, Ravi F. Sood, Thomas Gallagher, Alexander J. Gougoutas, Shannon M. Colohan, Otway Louie, David W. Mathes, Peter C. Neligan & Hakim K. Said. (2016) Improved healthcare economic outcomes after liposomal bupivacaine administration in first-stage breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery 69:10, pages 1456-1457.
Crossref
Crossref
Rachel A. Knudson, Paul W. Dunlavy, Jan Franko, Shankar R. Raman & Soren R. Kraemer. (2016) Effectiveness of Liposomal Bupivacaine in Colorectal Surgery: A Pragmatic Nonsponsored Prospective Randomized Double Blinded Trial in a Community Hospital. Diseases of the Colon & Rectum 59:9, pages 862-869.
Crossref
Crossref
Brandon Glenn, Melissa Drum, Al Reader, Sara Fowler, John Nusstein & Mike Beck. (2016) Does Liposomal Bupivacaine (Exparel) Significantly Reduce Postoperative Pain/Numbness in Symptomatic Teeth with a Diagnosis of Necrosis? A Prospective, Randomized, Double-blind Trial. Journal of Endodontics 42:9, pages 1301-1306.
Crossref
Crossref
Yuchen Wang, Matthew S. Klein, Scott Mathis & Germin Fahim. (2016) Adductor Canal Block With Bupivacaine Liposome Versus Ropivacaine Pain Ball for Pain Control in Total Knee Arthroplasty. Annals of Pharmacotherapy 50:3, pages 194-202.
Crossref
Crossref
Matthew T. Charous & Brian M. Ilfeld. (2015) Liposome Bupivacaine for Postoperative Analgesia: One Formulation Approved for Clinical Use Within the United States. Current Anesthesiology Reports 5:2, pages 235-242.
Crossref
Crossref
E. Richard Kessler. (2014) Response to “Bupivacaine Liposomal versus Bupivacaine: Comparative Review”. Hospital Pharmacy 49:9, pages 793-795.
Crossref
Crossref